About the role of indacaterol in obstructive airways disorder: con Reportar como inadecuado




About the role of indacaterol in obstructive airways disorder: con - Descarga este documento en PDF. Documentación en PDF para descargar gratis. Disponible también para leer online.

Revista Portuguesa de Pneumología 2012, 18 1

Autor: J.M. Reis Ferreira

Fuente: http://www.redalyc.org/


Introducción



Revista Portuguesa de Pneumología ISSN: 0873-2159 sppneumologia@mail.telepac.pt Sociedade Portuguesa de Pneumologia Portugal Reis Ferreira, J.M. About the Role of Indacaterol in Obstructive Airways Disorder: CON Revista Portuguesa de Pneumología, vol.
18, núm.
1, enero-febrero, 2012, pp.
8-9 Sociedade Portuguesa de Pneumologia Lisboa, Portugal Available in: http:--www.redalyc.org-articulo.oa?id=169724478004 How to cite Complete issue More information about this article Journals homepage in redalyc.org Scientific Information System Network of Scientific Journals from Latin America, the Caribbean, Spain and Portugal Non-profit academic project, developed under the open access initiative Document downloaded from http:--www.elsevier.pt, day 28-03-2012.
This copy is for personal use.
Any transmission of this document by any media or format is strictly prohibited. Rev Port Pneumol.
2012;18(1):8---9 www.revportpneumol.org EDITORIAL About the Role of Indacaterol in Obstructive Airways Disorder: CON夽 A propósito do papel do Indacaterol na Patologia Obstrutiva das vias aéreas: CONTRA Chronic obstructive pulmonary disease (COPD), a condition characterized by not fully reversible, inexorably progressive airway obstruction, has benefited in the last decade of relevant therapeutic progress.
A prominent step forward was the settlement of effective and secure results in maintenance therapy.
However, one should bear in mind that this disease is heterogeneous.
In several clinical settings with different prognosis, a similar severity grade of airway obstruction may be found.1,2 This evidence has been recently reinforced, and seriously questions many conclusions in COPD studies on maintenance therapy.
In the case of a poor randomisation of populations, different groups may be under scrutiny, despite a comparable severity of obstruction. Indacaterol arises in this therapeutic setting pretending to represent a real advance, capable of protagonizing the choice of the p...





Documentos relacionados